Drug Shortage Report for UROCIT-K

Last updated on 2021-07-07

Report ID 139263
Drug Identification Number 01914022
Brand name UROCIT-K
Common or Proper name Potassium Citrate Extended Release Tablets
Company Name MISSION PHARMACAL COMPANY
Market Status CANCELLED POST MARKET
Active Ingredient(s) POTASSIUM CITRATE
Strength(s) 540MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100-ct
ATC code A12BA
ATC description POTASSIUM
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-03-01
Actual start date
Estimated end date 2021-07-30
Actual end date 2021-07-06
Shortage status Resolved
Updated date 2021-07-07
Company comments Delay in confirmation release testing by importer.
Health Canada comments
Tier 3 Status No
Contact Address 8000 INTERSTATE HIGHWAY 10 WEST
SAN ANTONIO, TEXAS
UNITED STATES 78230
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-07-07 English Compare
v9 2021-07-06 French Compare
v8 2021-07-06 English Compare
v7 2021-07-01 French Compare
v6 2021-07-01 English Compare
v5 2021-05-27 French Compare
v4 2021-05-27 English Compare
v3 2021-05-13 French Compare
v2 2021-05-13 English Compare
v1 2021-05-13 English Compare

Showing 1 to 10 of 10